Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer

Selective estrogen receptor modulators (SERMs) such as tamoxifen have proven to be effective in the treatment of estrogen receptor (ER) positive breast cancer. However, a major obstacle for such endocrine therapy is estrogen independent growth, leading to resistance, and the underlying mechanism is...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wan-Xin, Koirala, Pratirodh, Zhou, Huaixiang, Jiang, Jiahong, Zhang, Ziqiang, Yang, Liu, Mo, Yin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546148/
https://www.ncbi.nlm.nih.gov/pubmed/34697301
http://dx.doi.org/10.1038/s41419-021-04288-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546148/
https://www.ncbi.nlm.nih.gov/pubmed/34697301
http://dx.doi.org/10.1038/s41419-021-04288-1

Ejemplares similares